Old Web
English
Sign In
Acemap
>
authorDetail
>
M. Dontenwill
M. Dontenwill
Medicine
Immunology
Integrin
Ligand
Cancer research
7
Papers
57
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
825: Improved cytotoxic therapy by dual targeting of a5β1 integrin and p53 pathway in glioblastoma
2014
European Journal of Cancer
M. Dontenwill
Hana Janouskova
Guillaume Renner
Anne-Marie Ray
Fanny Noulet
Laurence Choulier
Nelly Etienne-Selloum
Maxime Lehmann
Isabelle Lelong-Rebel
S. Martín
Show All
Source
Cite
Save
Citations (0)
274 Integrin α5ß1 Plays a Critical Role in Resistance to Chemotherapy by Interfering With the P53 Pathway in High Grade Glioma
2012
European Journal of Cancer
Hana Janouskova
Anne Maglott
Dominique Guenot
Sophie Pinel
Pascal Chastagner
François Plénat
Natacha Entz-Werle
Julien Godet
S. Martín
M. Dontenwill
Show All
Source
Cite
Save
Citations (1)
C001: Central blood pressure effects of S 23515, a ligand highly selective for imidazoline receptors over α2-adrenoceptors.
1999
American Journal of Hypertension
V. Bruban
J. Feldman
Christian Jarry
Schann S
H. Greney
Elizabeth Scalbert
Pierre Renard
M. Dontenwill
Pascal Bousquet
Show All
Source
Cite
Save
Citations (0)
Imidazoline Receptors A New Concept in Central Regulation of the Arterial Blood Pressure
1992
American Journal of Hypertension
Pascal Bousquet
J. Feldman
Eduardo Tibiriçá
G. Bricca
H. Greney
M. Dontenwill
J. Stutzmann
Alain Belcourt
Show All
Source
Cite
Save
Citations (55)
1